All News

A form of artificial intelligence known as a deep learning convolutional neural network outperformed dermatologists in diagnosing malignant melanomas.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape

Researchers identified a promising biomarker for the PARP-inhibitor sensitivity in small cell lung cancer, which may help in determining the appropriate treatment for select patients.

Using gene editing to remove CD33, a protein targeted to treat acute myeloid leukemia with chimeric antigen receptor (CAR) T cells, from healthy stem cells could reduce toxicity experienced by CAR T-cell therapy.

What's so smart about smart bottles?

Pharmacists have an important role in screening for behavioral health disorders in patients with high-risk conditions, including diabetes.

Researchers identified a primary mechanism of inflammatory demyelination in the central nervous system during multiple sclerosis, which may lead to new therapeutic approaches.

Top news of the day from across the health care landscape

Patients with rare diseases often face a difficult and long diagnosis and treatment process.

Top news of the day from across the health care landscape

Both negative and positive outcomes have been observed in studies.

An extremely virulent (hypermucoviscous) strain of Klebsiella pneumoniae (K pneumoniae) that is resistant to carbapenem and colistin has been isolated for the first time from a patient in the United States.

The FDA has approved the CustomFlex Artificial Iris, the first stand-alone prosthetic iris available in the United States.

Researchers aimed to assess the relationship between fatigue in multiple sclerosis and inflammatory or other immunomediated markers.

FDA officials have approved the first generic versions of buprenorphine and naloxone (Suboxone, Mylan Technologies Inc and Dr. Reddy's Laboratories SA) sublingual film to treat opioid dependence.

Top news of the week from The American Journal of Pharmacy Benefits.

Top news of the day from across the health care landscape

Top news of the day from across the health care landscape

A retrospective observational study was published in PLOS One that investigated the safety and efficacy of rituximab in patients with progressive MS (PMS) and relapsing-remitting MS (RRMS)

Agency officials have given the green light to versions of buprenorphine and naloxone (Suboxone, Mylan Technologies Inc and Dr. Reddy's Laboratories SA) sublingual film.

Here is why to consider the dollars and data behind such pharmacy offerings.

Top news of the week from Specialty Pharmacy Times.

Those who can do this find that they have an advantage in dealing with patients, team members, and vendors.

Some vitamin deficiencies go unnoticed, but insidious vitamin deficiencies can make us miserable.

Timolol eyedrops may have a potential role in managing acute migraine for some patients.

Top news of the day from across the health care landscape

In response to the Trump Administration’s drug pricing blueprint, the American College of Rheumatology issued a set of policy principles on drug prices and access to rheumatology treatment.

A 2-part trial shows a new antibody that suppresses HIV when combined with antiretroviral therapy (ART).